Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 5Unknown 3Withdrawn 1Suspended 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 46Triple Negative Breast Neoplasms 10Colorectal Neoplasms 6Prostatic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Uterine Cervical Neoplasms 3Ovarian Neoplasms 3Neoplasm Metastasis 3Carcinoma, Renal Cell 3Stomach Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Melanoma 2Lung Neoplasms 2Endometrial Neoplasms 2Colonic Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Vulvar Neoplasms 1Vaginitis 1Uterine Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Osteosarcoma 1Multiple Myeloma 1Margins of Excision 1Lymphedema 1Liver Neoplasms 1Hypertension 1

Interventions

Testosterone Propionate 1Testosterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Dyspareunia × Breast × Clear all
NCT01122342 2010-05-13

Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.

University of Vermont

Phase 1/2 Suspended
30 enrolled
Breast

Breast Neoplasms, Dyspareunia, Vaginitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡